| Q40621680 | A Modified SCID Mouse Model of HIV Infection with Utility for Testing Anti-HIV Therapies |
| Q47399665 | A mightier mouse with human adaptive immunity |
| Q36111849 | Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient? |
| Q41537754 | Alloimmune Responses of Humanized Mice to Human Pluripotent Stem Cell Therapeutics |
| Q34050742 | Animal models for AIDS pathogenesis |
| Q38050763 | Animal models on HTLV-1 and related viruses: what did we learn? |
| Q45723526 | Assessment of oral transmission using cell-free human immunodeficiency virus-1 in mice reconstituted with human peripheral blood leucocyte |
| Q34058486 | Bone marrow mesenchymal stem cells for improving hematopoietic function: an in vitro and in vivo model. Part 2: Effect on bone marrow microenvironment. |
| Q35594398 | Breaking the species barrier: use of SCID mouse-human chimeras for the study of human infectious diseases |
| Q37195155 | Can humanized mice reflect the complex pathobiology of HIV-associated neurocognitive disorders? |
| Q42591807 | Comparative study of human hematopoietic cell engraftment into BALB/c and C57BL/6 strain of rag-2/jak3 double-deficient mice |
| Q39971262 | Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice |
| Q40656354 | Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/γcnull mice model |
| Q34501933 | Creation of "humanized" mice to study human immunity |
| Q33553918 | Creation of an immunodeficient HLA-transgenic mouse (HUMAMICE) and functional validation of human immunity after transfer of HLA-matched human cells. |
| Q34474320 | Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis |
| Q38884521 | Development of Humanized Mice in the Age of Genome Editing. |
| Q33520247 | Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge |
| Q24531320 | Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice |
| Q44298281 | E2F-1-deficient NOD/SCID mice developed showing decreased saliva production |
| Q44953364 | Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment |
| Q78382775 | Effects of human interleukin-18 and interleukin-12 treatment on human lymphocyte engraftment in NOD-scid mouse |
| Q44443580 | Engraftment of canine peripheral blood lymphocytes into nonobese diabetic-severe combined immune deficient IL-2R common gamma chain null mice |
| Q58478774 | Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain |
| Q41919588 | Exploring the Immunopathogenesis of Viral Hemorrhagic Fever in Mice with a Humanized Immune System |
| Q33911359 | Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells |
| Q36453843 | Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice. |
| Q37608438 | Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells |
| Q37676228 | HIV-1 immunopathogenesis in humanized mouse models |
| Q36279270 | HIV-1 is not a major driver of increased plasma IL-6 levels in chronic HIV-1 disease |
| Q39213703 | Human B-1 and B-2 B Cells Develop from Lin-CD34+CD38lo Stem Cells |
| Q33577374 | Human allograft rejection in humanized mice: a historical perspective |
| Q35545282 | Human cancer growth and therapy in immunodeficient mouse models |
| Q54637726 | Human cord blood--derived cells generate insulin-producing cells in vivo. |
| Q33995307 | Human hemato-lymphoid system mice: current use and future potential for medicine |
| Q43233892 | Human interleukin-15 improves engraftment of human T cells in NOD-SCID mice |
| Q37981545 | Human lymphohematopoietic reconstitution and immune function in immunodeficient mice receiving cotransplantation of human thymic tissue and CD34(+) cells |
| Q84360672 | Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex |
| Q92881586 | Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises |
| Q64228779 | Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies |
| Q26771440 | Humanized hemato-lymphoid system mice |
| Q34607151 | Humanized mice in translational biomedical research |
| Q26996648 | Humanized mice: novel model for studying mechanisms of human immune-based therapies |
| Q34141837 | Immune reconstitution from peripheral blood mononuclear cells inhibits lung carcinoma growth in NOD/SCID mice |
| Q35747109 | Immunological characterization of human vaginal xenografts in immunocompromised mice: development of a small animal model for the study of human immunodeficiency virus-1 infection |
| Q46069567 | In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood |
| Q36753942 | In vivo expansion of co-transplanted T cells impacts on tumor re-initiating activity of human acute myeloid leukemia in NSG mice |
| Q45970875 | Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. |
| Q39239278 | Modeling Natural Killer Cell Targeted Immunotherapies. |
| Q49914671 | Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches |
| Q38937610 | Mouse models for pre-clinical drug testing in leukemia |
| Q37737987 | Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease |
| Q37365361 | Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model |
| Q49171667 | Murine IL-2 receptor beta chain blockade improves human leukocyte engraftment in SCID mice |
| Q53454854 | Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. |
| Q37034635 | Nonprimate models of HIV-1 infection and pathogenesis |
| Q37254483 | Overcoming current limitations in humanized mouse research |
| Q33716675 | Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. |
| Q47864989 | Peritoneal macrophages play an important role in eliminating human cells from severe combined immunodeficient mice transplanted with human peripheral blood lymphocytes |
| Q37333100 | Potent activity of a nucleoside reverse transcriptase inhibitor, 4'-ethynyl-2-fluoro-2'-deoxyadenosine, against human immunodeficiency virus type 1 infection in a model using human peripheral blood mononuclear cell-transplanted NOD/SCID Janus kinase |
| Q39878783 | Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain |
| Q84068289 | Rag2-/- gamma-chain-/- mice as hosts for human vessel transplantation and allogeneic human leukocyte reconstitution |
| Q27013114 | Recent developments in human immunodeficiency virus-1 latency research |
| Q34525894 | Reconstitution of huPBL-NSG mice with donor-matched dendritic cells enables antigen-specific T-cell activation |
| Q80373630 | Role of peptide antigen for induction of inhibitory antibodies to Streptococcus mutans in human oral cavity |
| Q34470843 | SCID mouse models of human stem cell engraftment |
| Q26849806 | Studies of retroviral infection in humanized mice |
| Q40797481 | Susceptibility of B-cell lymphoma to human antibodies encoded by the V4-34 gene |
| Q35112331 | The NOD/SCID chimeric mouse model of human B cell development: studies on the VH4 family immunoglobulin repertoire and implications for SLE |
| Q54244413 | The use of humanized mice for studies of viral pathogenesis and immunity. |
| Q37346027 | The utilization of humanized mouse models for the study of human retroviral infections |
| Q60267505 | U937-SCID mouse xenografts: a new model for acute in vivo HIV-1 infection suitable to test antiviral strategies |
| Q86848619 | [Development of immunodeficient mice/humanized mouse models and their applications in hematology research] |